BRIEF-Century Therapeutics To Reduce Headcount By 51%

Reuters

Jul 08

BRIEF-Century <a href="https://laohu8.com/S/LENZ">Therapeutics</a> To Reduce Headcount By 51%

July 7 (Reuters) - Century Therapeutics Inc IPSC.O:

CENTURY THERAPEUTICS INC - TO REDUCE HEADCOUNT BY 51% - SEC FILING
CENTURY THERAPEUTICS INC - DEPARTURE OF CFO MORGAN CONN AND CDO ADRIENNE FARID - SEC FILING
CENTURY THERAPEUTICS INC - ESTIMATES $3.7 MILLION IN SEVERANCE COSTS - SEC FILING
CENTURY THERAPEUTICS INC - DOUGLAS CARR TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING
CENTURY THERAPEUTICS INC: ESTIMATES WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY Q3 2025

Further company coverage: IPSC.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2549563562"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2549563562\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2549563562?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-08 05:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2549563562","market":"fut","top_or_hot":-1,"title":"BRIEF-Century Therapeutics To Reduce Headcount By 51%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Century <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> To Reduce Headcount By 51%</title></head><body><p><span>July 7 (Reuters)</span><span> - </span>Century Therapeutics Inc <span>IPSC.O</span>:</p><ul><li><p>CENTURY THERAPEUTICS INC - TO REDUCE HEADCOUNT BY 51% - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC - DEPARTURE OF CFO MORGAN CONN AND CDO ADRIENNE FARID - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC - ESTIMATES $3.7 MILLION IN SEVERANCE COSTS - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC - DOUGLAS CARR TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC: ESTIMATES WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY Q3 2025</p></li></ul><p>Further company coverage: <span>IPSC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Century Therapeutics To Reduce Headcount By 51%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Century Therapeutics To Reduce Headcount By 51%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-08 05:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Century <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> To Reduce Headcount By 51%</title></head><body><p><span>July 7 (Reuters)</span><span> - </span>Century Therapeutics Inc <span>IPSC.O</span>:</p><ul><li><p>CENTURY THERAPEUTICS INC - TO REDUCE HEADCOUNT BY 51% - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC - DEPARTURE OF CFO MORGAN CONN AND CDO ADRIENNE FARID - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC - ESTIMATES $3.7 MILLION IN SEVERANCE COSTS - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC - DOUGLAS CARR TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING</p></li><li><p>CENTURY THERAPEUTICS INC: ESTIMATES WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY Q3 2025</p></li></ul><p>Further company coverage: <span>IPSC.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nFWN3T40MV:1","article_id":"2549563562","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2549563562","pubTimestamp":1751925329,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Century Therapeutics To Reduce Headcount By 51%July 7  - Century Therapeutics Inc IPSC.O:CENTURY THERAPEUTICS INC - TO REDUCE HEADCOUNT BY 51% - SEC FILINGCENTURY THERAPEUTICS INC - DEPARTURE OF CFO MORGAN CONN AND CDO ADRIENNE FARID - SEC FILINGCENTURY THERAPEUTICS INC - ESTIMATES $3.7 MILLION IN SEVERANCE COSTS - SEC FILINGCENTURY THERAPEUTICS INC - DOUGLAS CARR TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILINGCENTURY THERAPEUTICS INC: ESTIMATES WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY Q3 2025Further company coverage: IPSC.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","BK4505":"高瓴资本持仓","BK4539":"次新股","IPSC":"Century Therapeutics, Inc."},"translate_title":"BRIEF-Century Therapeutics将裁员51%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IPSC":0.9},"content_text":"BRIEF-Century Therapeutics To Reduce Headcount By 51%July 7 (Reuters) - Century Therapeutics Inc IPSC.O:CENTURY THERAPEUTICS INC - TO REDUCE HEADCOUNT BY 51% - SEC FILINGCENTURY THERAPEUTICS INC - DEPARTURE OF CFO MORGAN CONN AND CDO ADRIENNE FARID - SEC FILINGCENTURY THERAPEUTICS INC - ESTIMATES $3.7 MILLION IN SEVERANCE COSTS - SEC FILINGCENTURY THERAPEUTICS INC - DOUGLAS CARR TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILINGCENTURY THERAPEUTICS INC: ESTIMATES WORKFORCE REDUCTION TO BE SUBSTANTIALLY COMPLETED BY Q3 2025Further company coverage: IPSC.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}